- ¥247bn
- ¥865bn
- ¥661bn
Table: Nipro -2017/18 div forecast
Brief: Yuki Gosei Kogyo says NIPRO to sell 5 pct stake in co to Nagase
Table: Nipro - 9-MTH group results
Brief: R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I
Table: Nipro - 6-MTH group results
Table: Nipro -2017/18 div forecast
Table: Nipro -2017/18 group forecast
Table: Nipro -Q1 group results
Brief: Lilly gets civil investigative demand from Minnesota AG for insulin product pricing
Table: Nipro -2016/17 parent results
Table: Nipro -2016/17 group results
Table: Nipro -2016/17 div forecast
Brief: Mitsubishi Tanabe Pharma to sell drug sales unit to Nipro after company division
Brief: NIPRO sets up medical machinery manufacture unit in Vietnam
Table: Nipro -9-MTH group results
Brief: Nipro completes 3.9 mln shares' buy-back
Table: Nipro -6-MTH group results
Table: Nipro -2016/17 div forecast
Table: Nipro -2016/17 group forecast